| Literature DB >> 30257227 |
Katia Todoerti1, Giovanni Calice1, Stefania Trino1, Vittorio Simeon1, Marta Lionetti2, Martina Manzoni2, Sonia Fabris2, Marzia Barbieri2, Alessandra Pompa3, Luca Baldini2, Valentina Bollati4, Pietro Zoppoli1, Antonino Neri5, Pellegrino Musto6.
Abstract
Primary plasma cell leukemia (pPCL) is a rare and very aggressive variant of multiple myeloma (MM). Specific clinical, biological and molecular patterns distinguish pPCL from MM. Here, we performed a genome-wide methylation analysis by high-density array in 14 newly diagnosed pPCL patients along with 60 MMs, and 5 patients affected by monoclonal gammopathy of uncertain significance (MGUS). Our analysis revealed a global hypomethylation profile associated with pPCL. Additionally, differential methylation patterns were found related to distinct chromosomal aberrations and DIS3 mutations, affecting genes with roles in bone metabolism, cell migration, transcription regulation or DNA damage response. When compared with MM patients, pPCL showed a distinct methylation profile mostly characterized by hypomethylated probes specific for genes involved in several processes like cell adhesion and migration. Furthermore, decreasing methylation levels were evidenced for genes significantly modulated in the progressive phases of plasma cell dyscrasias, from MGUS to MM and pPCL. Overall, our data provide new insights into the molecular characterization of pPCL, thus being potentially useful in the prognostic stratification or identification of novel molecular targets.Entities:
Keywords: Gene expression; Methylation; Microarray profiling; Plasma cell leukemia
Mesh:
Substances:
Year: 2018 PMID: 30257227 DOI: 10.1016/j.leukres.2018.09.007
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156